Spectrum Pharmaceuticals | Eigenkapital Und Reserven

Equity Capital And Reserves Veränderung Datum
AbbVie USD 12.09B 772M 2023-09
Agios Pharmaceuticals USD 811.02M 75.82M 2023-12
Alnylam Pharmaceuticals USD -220644000 54.78M 2023-12
Amgen USD 6.23B 1.42B 2023-12
Arrowhead Research USD 160.41M 110.94M 2023-12
AstraZeneca USD 37.2B 195M 2023-09
Bayer EUR 33.38B 3.57B 2023-09
Eli Lilly USD 11.22B 156.6M 2023-09
GlaxoSmithKline GBP 13.13B 442M 2023-09
Incyte USD 5.19B 258.39M 2023-12
Pfizer USD 96.93B 2.08B 2023-09
Roche Holding CHF 26.52B 1.48B 2023-06
Takeda JPY 7.07T 149.3B 2023-09
Teva Pharmaceutical Industries USD 6.93B 122M 2023-09
TG Therapeutics USD 160.5M 4.27M 2023-12



Spectrum Pharmaceuticals Eigenkapital Und Reserven - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2024.